[1]
2020. Assessment of the REPLACE study composite endpoint in the PATENT study and association with long-term outcomes in riociguat-treated patients. Revista Colombiana de NeumologĂ­a. 31, 2 (Dec. 2020). DOI:https://doi.org/10.30789/rcneumologia.v31.n2.2019.451.